Trial intelligence / Profile preview

Ropivacaine LIA in Vaginal Prolapse Repair

NCT00769054Phase 4Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Oct 2008
Primary completion
Oct 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in vaginal prolapse comparing Ropivacaine with Placebo (2 arms). Primary endpoint: Postoperative Pain during rest, coughing and ambulation at 24 hours. Started Oct 2008; status: completed.

02

Drugs

ropivacaine
03

Conditions

vaginal prolapse

Beyond the preview

Go deeper on NCT00769054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00769054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call